Feng Zheng Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

7/2022	NOAC Compared to Aspirin may not Significantly Reduce the Rate of Ischaemic Stroke in Patients with Mixed Cardiovascular Disease in Sinus Rhythm.
10/2009	Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Feng Zheng Research Topics

Disease

18	Neoplasms (Cancer) 06/2022 - 07/2006
18	Inflammation (Inflammations) 10/2021 - 07/2006
9	Fibrosis (Cirrhosis) 01/2022 - 08/2008
8	Infections 01/2020 - 10/2007
7	Acute Kidney Injury (Acute Renal Failure) 02/2022 - 03/2011
7	Diabetic Nephropathies (Diabetic Nephropathy) 10/2011 - 02/2002
6	Sepsis (Septicemia) 10/2021 - 10/2015
5	Insulin Resistance 12/2016 - 08/2005
4	Hypoxia (Hypoxemia) 06/2022 - 01/2013
4	Stroke (Strokes) 12/2021 - 01/2017
4	Cognitive Dysfunction 01/2021 - 12/2016
4	Anaphylaxis (Anaphylactic Shock) 01/2017 - 10/2012
3	Myocardial Infarction 01/2022 - 08/2015
3	Stomach Neoplasms (Stomach Cancer) 09/2020 - 07/2006
3	Anthrax 11/2019 - 01/2017
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 07/2006
3	Chronic Renal Insufficiency 06/2018 - 12/2009
3	Hypotension (Low Blood Pressure) 01/2017 - 10/2012
3	Sclerosis 01/2014 - 02/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 10/2009
2	Ischemic Stroke 07/2022 - 05/2022
2	Infarction (Infarctions) 01/2022 - 08/2015
2	Body Weight (Weight, Body) 01/2022 - 08/2005
2	Type 2 Diabetes Mellitus (MODY) 10/2021 - 09/2020
2	Virus Diseases (Viral Diseases) 01/2021 - 08/2019
2	Pneumonia (Pneumonitis) 01/2021 - 01/2017
2	Neuroinflammatory Diseases 01/2021 - 01/2020
2	Airway Obstruction (Choking) 12/2020 - 01/2017
2	Necrosis 11/2020 - 07/2012
2	Hypertension (High Blood Pressure) 09/2020 - 01/2018
2	Triple Negative Breast Neoplasms 12/2019 - 11/2018
2	Pulmonary Edema 10/2019 - 03/2016
2	Acute Lung Injury 10/2019 - 03/2016
2	Neoplasm Metastasis (Metastasis) 06/2019 - 07/2014
2	Fatty Liver 01/2019 - 01/2017
2	Diabetes Complications 01/2019 - 06/2009
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 06/2003
2	Disease Progression 01/2019 - 05/2008
2	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2016
2	Lung Injury 07/2018 - 03/2016
2	Hyperglycemia 01/2018 - 10/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2017 - 01/2016
2	Rupture 10/2017 - 01/2013

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2006
9	Pharmaceutical PreparationsIBA 06/2022 - 01/2013
9	Glucose (Dextrose)FDA LinkGeneric 04/2017 - 02/2002
6	C-Reactive ProteinIBA 01/2020 - 06/2009
5	Advanced Glycation End ProductsIBA 12/2009 - 06/2009
4	Therapeutic UsesIBA 11/2021 - 08/2014
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 11/2009
4	CytokinesIBA 01/2019 - 01/2011
3	Hyaluronic Acid (Hyaluronan)IBA 06/2022 - 11/2018
3	Pregnane X ReceptorIBA 02/2022 - 01/2021
3	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 01/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2017
3	Immunoglobulin G (IgG)IBA 11/2020 - 08/2012
3	MicroRNAs (MicroRNA)IBA 09/2020 - 01/2018
3	Toll-Like Receptor 4IBA 01/2020 - 03/2009
3	Hemoglobins (Hemoglobin)IBA 05/2019 - 07/2006
3	LipidsIBA 01/2019 - 08/2005
3	Insulin (Novolin)FDA Link 01/2019 - 08/2005
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019 - 12/2009
3	LigandsIBA 11/2018 - 05/2008
3	ProcalcitoninIBA 07/2018 - 04/2017
3	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 01/2018 - 10/2011
3	Epinephrine (Adrenaline)FDA LinkGeneric 01/2017 - 01/2013
3	AntigensIBA 01/2017 - 11/2009
3	OvalbuminIBA 01/2017 - 10/2012
3	LipopolysaccharidesIBA 10/2015 - 06/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2014 - 06/2012
3	Oxidants (Oxidizing Agents)IBA 12/2009 - 07/2006
3	PPAR gammaIBA 09/2008 - 04/2002
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2022 - 01/2016
2	Oxygen (Dioxygen)IBA 06/2022 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 11/2009
2	CholesterolIBA 11/2021 - 01/2021
2	Sevoflurane (Ultane)FDA LinkGeneric 01/2021 - 04/2020
2	Messenger RNA (mRNA)IBA 11/2020 - 01/2020
2	Methylene Blue (Methylthioninium Chloride)FDA Link 04/2020 - 01/2013
2	ChitosanIBA 12/2019 - 11/2018
2	OligosaccharidesIBA 12/2019 - 11/2018
2	gambogic acidIBA 12/2019 - 11/2018
2	Biological ProductsIBA 01/2019 - 01/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 10/2009
2	Angiotensin IIIBA 01/2019 - 07/2018
2	Phosphopyruvate Hydratase (Enolase)IBA 07/2018 - 11/2009
2	SaltsIBA 01/2018 - 03/2016
2	Streptozocin (Streptozotocin)FDA Link 01/2018 - 12/2009
2	Carbon DioxideIBA 04/2017 - 03/2016

Therapy/Procedure

16	Therapeutics 06/2022 - 11/2009
4	Drug Therapy (Chemotherapy) 01/2019 - 01/2013
3	Gastrectomy 09/2020 - 07/2006
3	Resuscitation 03/2016 - 10/2012
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2021 - 09/2015
2	Glycemic Control 10/2021 - 01/2019
2	Ligation 10/2021 - 01/2016
2	Immunotherapy 01/2021 - 01/2019
2	Cesarean Section (Caesarean Section) 01/2021 - 01/2020